Caprion of Montreal Raises $4.1M for Proteomics Efforts | GenomeWeb

NEW YORK, March 13 – Canadian proteomics company Caprion Pharmaceuticals said Tuesday it had raised C$6.2 million ($4.1 million) in a secondary round of private financing managed by Yorkton Securities and led by Ventures West and Fidelity Management & Research.

Caprion of Montreal has raised a total of C$58.1 million to date, not including a C$11.6 million investment from Micromass for the application of Micromass' mass spectrometry technologies to Caprion's proteomics efforts.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: global genetic diversity map, and more.

The Nuffield Council on Bioethics identifies ethical questions to explore surrounding genome editing.

In a blog post, Brigham and Women's Hospital's Robert Green discusses "predispositional personal genome sequencing."

Stat News reports that there's muted opposition to the Kuwaiti DNA database law.